NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
As of today, NovoCure(NVCR) shares are valued at $16.68. The company's market cap stands at 1.94B, with a P/E ratio of -13.70.
On 2026-09-08, NovoCure(NVCR) stock moved within a range of $16.61 to $17.78. With shares now at $16.68, the stock is trading +0.4% above its intraday low and -6.2% below the session's peak.
Trading volume for NovoCure(NVCR) stock has reached 689.91K, versus its average volume of 978.49K.
The stock's 52-week range extends from a low of $9.82 to a high of $21.45.
The stock's 52-week range extends from a low of $9.82 to a high of $21.45.
NVCR News
...
NovoCure Ltd. (NVCR) announced an update on their ongoing clinical study. The PANOVA-4 study, officially titled “PANOVA-4: Pilot, Single Arm Study of Tumor Tre...
NovoCure stock has had a strong rebound in recent months, yet long term shareholders are still sitting on a deep drawdown, which makes the current valuation esp...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.